Cardiotoxicity and Chemotherapy-The Role of Precision Medicine.
Ontology highlight
ABSTRACT: Cancer and cardiovascular disease are the leading causes of death in the United Kingdom. Many systemic anticancer treatments are associated with short- and long-term cardiotoxicity. With improving cancer survival and an ageing population, identifying those patients at the greatest risk of cardiotoxicity from their cancer treatment is becoming a research priority and has led to a new subspecialty: cardio-oncology. In this concise review article, we discuss cardiotoxicity and systemic anticancer therapy, with a focus on chemotherapy. We also discuss the challenge of identifying those at risk and the role of precision medicine as we strive for a personalised approach to this clinical scenario.
SUBMITTER: Viswanathan T
PROVIDER: S-EPMC8699963 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA